Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 4:00 pm Purchase |
2024-01-19 | 13G | Ventyx Biosciences, Inc. VTYX |
TANG CAPITAL PARTNERS LP | 3,100,000 5.200% |
3,100,000 (New Position) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
BlackRock Inc. BLK |
3,814,531 6.500% |
3,814,531 (New Position) |
Filing History |
| 2023-12-11 09:09 am Sale |
2023-12-08 | 13G | Ventyx Biosciences, Inc. VTYX |
FMR LLC | 322,615 0.546% |
-7,281,726 (-95.76%) |
Filing History |
| 2023-07-19 5:03 pm Purchase |
2023-07-07 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 8,556,866 14.600% |
34,242 (+0.40%) |
Filing History |
| 2023-07-11 4:02 pm Sale |
2023-07-07 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 8,522,624 14.600% |
-1,554,421 (-15.43%) |
Filing History |
| 2023-04-10 09:37 am Purchase |
2023-04-06 | 13G | Ventyx Biosciences, Inc. VTYX |
FMR LLC | 7,604,341 13.062% |
7,604,341 (New Position) |
Filing History |
| 2023-04-07 5:13 pm Sale |
2023-04-06 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 10,077,045 17.300% |
-1,747,098 (-14.78%) |
Filing History |
| 2023-03-22 3:45 pm Sale |
2023-03-17 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 11,824,143 20.900% |
-1,150,643 (-8.87%) |
Filing History |
| 2023-03-02 4:56 pm Unchanged |
2023-02-24 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 12,974,786 22.900% |
0 (Unchanged) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,788,795 6.700% |
-102,278 (-2.63%) |
Filing History |
| 2023-01-30 5:25 pm Sale |
2023-01-27 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 2,720,994 4.800% |
-749,502 (-21.60%) |
Filing History |
| 2022-12-30 5:05 pm Unchanged |
2022-12-30 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 12,974,786 22.900% |
0 (Unchanged) |
Filing History |
| 2022-12-16 5:21 pm Sale |
2022-12-13 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 12,974,786 22.900% |
-3,917,742 (-23.19%) |
Filing History |
| 2022-12-15 5:00 pm Sale |
2022-12-13 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 3,470,496 6.100% |
-1,541,040 (-30.75%) |
Filing History |
| 2022-11-09 5:04 pm Sale |
2022-11-07 | 13D | Ventyx Biosciences, Inc. VTYX |
Third Point LLC | 2,252,432 4.000% |
-2,060,402 (-47.77%) |
Filing History |
| 2022-09-20 9:25 pm Unchanged |
2022-09-17 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 16,892,528 30.000% |
0 (Unchanged) |
Filing History |
| 2022-09-14 5:01 pm Unchanged |
2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 5,011,536 9.950% |
0 (Unchanged) |
Filing History |
| 2022-02-14 06:26 am Purchase |
2021-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,891,073 7.700% |
455,133 (+13.25%) |
Filing History |
| 2021-11-04 5:11 pm Purchase |
2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX |
Third Point LLC | 4,312,834 8.570% |
4,312,834 (New Position) |
Filing History |
| 2021-11-04 4:21 pm Purchase |
2021-10-25 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 3,435,940 6.800% |
3,435,940 (New Position) |
Filing History |